Oncko
PrivateLast Round
Seed
Feb 1, 2026
Total Funding Raised
$5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oncko operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in February 2026.
Oncko is a biotechnology company that develops optimized combination drug therapies to treat advanced cancers by leveraging experimental platforms and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncko Comparables
Compare Oncko with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noetik | 74% | |
| PerturbAI | 72% | |
| Certis Oncology Solutions | 71% |
For institutional investors. Book with your work email.
Oncko Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oncko Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Seed |
| Adverb Ventures | Seed |
| Tenmile | Seed |
| Illumina Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 9, 2026
Grew 50% QoQ, from 6 to 9 employees.
- Feb 1, 2026
$5M round with participation from Gaingels and Illumina Ventures.
For institutional investors. Book with your work email.
Oncko Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oncko's valuation, stock price, and market status.
Is Oncko a public or private company?
Oncko is a private company.
What is the current stock price of Oncko?
Oncko is a private company, so its shares have no public market price. Caplight tracks Oncko's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oncko worth (valuation)?
Valuation information for Oncko is not publicly available.
Can I buy Oncko stock?
Oncko shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oncko's last funding round?
Oncko's most recent funding round was Seed on February 1, 2026.
Who are the main investors in Oncko?
Key investors in Oncko include Gaingels, Adverb Ventures, Tenmile, Illumina Ventures.
Will Oncko IPO soon?
No public IPO plans have been announced for Oncko.
How can I track Oncko secondary market activity?
Caplight tracks bids, offers, and trades in Oncko's shares on secondary markets.